Migdalor- Alternative Products Past Earnings Performance
Past criteria checks 0/6
Migdalor- Alternative Products's earnings have been declining at an average annual rate of -211%, while the Capital Markets industry saw earnings growing at 15.1% annually. Revenues have been declining at an average rate of 54.6% per year.
Key information
-211.0%
Earnings growth rate
-249.4%
EPS growth rate
| Capital Markets Industry Growth | 15.1% |
| Revenue growth rate | -54.6% |
| Return on equity | -11.1% |
| Net Margin | -29.7% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Migdalor- Alternative Products makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 20 | -6 | 28 | 0 |
| 31 Mar 23 | 27 | -2 | 27 | 0 |
| 31 Dec 22 | 35 | 1 | 27 | 0 |
| 30 Jun 22 | 43 | 5 | 29 | 0 |
| 31 Mar 22 | 39 | 4 | 27 | 0 |
| 31 Dec 21 | 34 | 3 | 24 | 0 |
| 31 Dec 20 | 17 | 0 | 15 | 0 |
Quality Earnings: MGDA is currently unprofitable.
Growing Profit Margin: MGDA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if MGDA's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare MGDA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MGDA is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (9.2%).
Return on Equity
High ROE: MGDA has a negative Return on Equity (-11.14%), as it is currently unprofitable.